| Silkii Renee Fitzhugh, | |
|
1120 Indian Hedge Dr, North Las Vegas, NV 89032-7665 | |
| (702) 772-4682 | |
| Not Available |
| Full Name | Silkii Renee Fitzhugh |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 1120 Indian Hedge Dr, North Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043654353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Silkii Renee Fitzhugh, 1120 Indian Hedge Drive, North Las Vegas, NV 89032 Ph: (702) 772-4682 | Silkii Renee Fitzhugh, 1120 Indian Hedge Dr, North Las Vegas, NV 89032-7665 Ph: (702) 772-4682 |
News Archive
University of Texas at El Paso researchers have patented a low-cost device that can easily monitor the health of HIV patients living in low-resource settings.
A new study from the Human Factors Safety Laboratory at Ben-Gurion University of the Negev indicates that advanced age does not affect older drivers' ability to perceive hazards and that older drivers are more sensitive to potential hazards than young-inexperienced drivers.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
Scientists at the University of Liverpool have shown that young people who show impulsive tendencies are more prone to drinking heavily at an early age.
Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.
› Verified 2 days ago
Amanda Nicole Vieira, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 211 Judson Ave, North Las Vegas, NV 89030 Phone: 702-399-2769 Fax: 702-399-0271 | |
Gerard Taguiam, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7016 Manzanares Dr, North Las Vegas, NV 89084 Phone: 510-759-1966 | |
Abby Lynn Pike, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3920 W Ann Rd Ste 100, North Las Vegas, NV 89031 Phone: 702-437-4673 Fax: 702-438-4673 | |
Gerimar Deon Hicks, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2024 Hassell Ave, North Las Vegas, NV 89032 Phone: 702-205-7638 | |
Samuel Harris, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1829 Casa Verde Dr, North Las Vegas, NV 89031 Phone: 702-636-0337 | |
Lizeth Pineda Florez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3404 Robust Robin Pl Unit 1, North Las Vegas, NV 89084 Phone: 702-429-1303 | |
Sonya Edyth Michelle Wells, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3925 N Martin L King, North Las Vegas, NV 89032 Phone: 702-684-7757 |